On Wednesday, the Danish pharmaceutical company and Anthropic, the company behind AI model Claude, announced its partnership.
According to a press release from the former, the companies will jointly address some of the challenges faced by Novo’s scientists in drug development.
Claude is widely known as a large language model, an LLM. In this case, it will be used to compare large amounts of data to increase the speed and efficiency of drug development.